Search

Your search keyword '"de Hartog, J.J."' showing total 6 results
Start Over Author "de Hartog, J.J." Publisher public health services, us dept of health and human services
6 results on '"de Hartog, J.J."'

1. Do the health benefits of cycling outweigh the risks?

Author

Risk Assessment of Toxic and Immunomodulatory Agents, Dep IRAS, de Hartog, J.J., Boogaard, H., Nijland, H., Hoek, G., Risk Assessment of Toxic and Immunomodulatory Agents, Dep IRAS, de Hartog, J.J., Boogaard, H., Nijland, H., and Hoek, G.

Published
2010

2. Do the health benefits of cycling outweigh the risks?

Author

Risk Assessment of Toxic and Immunomodulatory Agents, Dep IRAS, de Hartog, J.J., Boogaard, H., Nijland, H., Hoek, G., Risk Assessment of Toxic and Immunomodulatory Agents, Dep IRAS, de Hartog, J.J., Boogaard, H., Nijland, H., and Hoek, G.

Published
2010

3. Do the health benefits of cycling outweigh the risks?

Author

Risk Assessment of Toxic and Immunomodulatory Agents, Dep IRAS, de Hartog, J.J., Boogaard, H., Nijland, H., Hoek, G., Risk Assessment of Toxic and Immunomodulatory Agents, Dep IRAS, de Hartog, J.J., Boogaard, H., Nijland, H., and Hoek, G.

Published
2010

4. Associations between PM2.5 and heart rate variability are modified by particle composition and beta-blocker use in patients with coronary heart disease.

Author

Risk Assessment of Toxic and Immunomodulatory Agents, Dep IRAS, de Hartog, J.J., Lanki, T., Timonen, K.L., Hoek, G., Janssen, N.A.H., Ibald-Mulli, A., Peters, A., Heinrich, J., Tarkiainen, T., Van Grieken, R., van Wijnen, J.H., Brunekreef, B., Pekkanen, J., Risk Assessment of Toxic and Immunomodulatory Agents, Dep IRAS, de Hartog, J.J., Lanki, T., Timonen, K.L., Hoek, G., Janssen, N.A.H., Ibald-Mulli, A., Peters, A., Heinrich, J., Tarkiainen, T., Van Grieken, R., van Wijnen, J.H., Brunekreef, B., and Pekkanen, J.

Published
2009

5. Associations between PM2.5 and heart rate variability are modified by particle composition and beta-blocker use in patients with coronary heart disease.

Author

Risk Assessment of Toxic and Immunomodulatory Agents, Dep IRAS, de Hartog, J.J., Lanki, T., Timonen, K.L., Hoek, G., Janssen, N.A.H., Ibald-Mulli, A., Peters, A., Heinrich, J., Tarkiainen, T., Van Grieken, R., van Wijnen, J.H., Brunekreef, B., Pekkanen, J., Risk Assessment of Toxic and Immunomodulatory Agents, Dep IRAS, de Hartog, J.J., Lanki, T., Timonen, K.L., Hoek, G., Janssen, N.A.H., Ibald-Mulli, A., Peters, A., Heinrich, J., Tarkiainen, T., Van Grieken, R., van Wijnen, J.H., Brunekreef, B., and Pekkanen, J.

Published
2009

6. Associations between PM2.5 and heart rate variability are modified by particle composition and beta-blocker use in patients with coronary heart disease.

Author

Risk Assessment of Toxic and Immunomodulatory Agents, Dep IRAS, de Hartog, J.J., Lanki, T., Timonen, K.L., Hoek, G., Janssen, N.A.H., Ibald-Mulli, A., Peters, A., Heinrich, J., Tarkiainen, T., Van Grieken, R., van Wijnen, J.H., Brunekreef, B., Pekkanen, J., Risk Assessment of Toxic and Immunomodulatory Agents, Dep IRAS, de Hartog, J.J., Lanki, T., Timonen, K.L., Hoek, G., Janssen, N.A.H., Ibald-Mulli, A., Peters, A., Heinrich, J., Tarkiainen, T., Van Grieken, R., van Wijnen, J.H., Brunekreef, B., and Pekkanen, J.

Published
2009

Catalog

Books, media, physical & digital resources
See catalog results